Anne Brindley
Keine laufenden Positionen mehr
Karriereverlauf von Anne Brindley
Ehemalige bekannte Positionen von Anne Brindley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Auroscience (Pty) Ltd. | Vorstandsvorsitzender | - | 01.02.2020 |
RespiVert Ltd.
 RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Vorstandsvorsitzender | 28.06.2013 | 28.02.2017 |
| GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.11.1992 | 01.12.1995 |
Advent Pharmaceuticals Pty Ltd.
 Advent Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Advent Pharmaceuticals Pty Ltd. designs and develops dry powder inhaler devices. The firm focuses on the development of dry powder inhalation platforms for the treatment of asthma and chronic obstructive pulmonary diseases. The company was founded by Henry Kenneth Windle in 2001 and is headquartered in Melbourne, Australia. | Vorstandsvorsitzender | - | - |
| NUFORMIX PLC | Direktor/Vorstandsmitglied | 07.12.2020 | - |
| Vorstandsvorsitzender | 07.12.2020 | - | |
| ASTRAZENECA PLC | Corporate Officer/Principal | - | - |
| SKYEPHARMA PLC | Corporate Officer/Principal | 22.11.2010 | - |
Ausbildung von Anne Brindley
| University of Bath | Undergraduate Degree |
| The University of Nottingham | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 8 |
| Australien | 3 |
Operativ
| Chief Executive Officer | 4 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| GSK PLC | Health Technology |
| NUFORMIX PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
SkyePharma Plc
 SkyePharma Plc Pharmaceuticals: OtherHealth Technology SkyePharma Plc engaged in the provision of pharmaceutical business. It involved in development and supply of pharmaceutical products. The company was founded by Ian Roderick Gowrie-Smith on August 18, 1910 and was headquartered in London, the United Kingdom. | Health Technology |
RespiVert Ltd.
RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Distribution Services |
Advent Pharmaceuticals Pty Ltd.
Advent Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Advent Pharmaceuticals Pty Ltd. designs and develops dry powder inhaler devices. The firm focuses on the development of dry powder inhalation platforms for the treatment of asthma and chronic obstructive pulmonary diseases. The company was founded by Henry Kenneth Windle in 2001 and is headquartered in Melbourne, Australia. | Health Technology |
| Auroscience (Pty) Ltd. |
- Börse
- Insiders
- Anne Brindley
- Erfahrung